Cutaneous Drug Eruptions in Pediatrics-A Primer.

Cutaneous Drug Eruptions in Pediatrics-A Primer. Pediatr Ann. 2020 Mar 01;49(3):e132-e139 Authors: Perez CE, Dyer JA Abstract Cutaneous adverse drug reactions (ADRs) are commonly seen in the pediatric population in both inpatient and outpatient settings and are important to identify, evaluate, and appropriately manage. Early recognition and proper classification of a cutaneous drug reaction allows the clinician the ability to narrow in on a culprit drug and determine whether the medication is safe to continue. This review discusses the clinical presentation, categorization, and management of cutaneous ADRs in the pediatric population. [Pediatr Ann. 2020;49(3):e132-e139.]. PMID: 32155279 [PubMed - as supplied by publisher]
Source: Pediatric Annals - Category: Pediatrics Authors: Tags: Pediatr Ann Source Type: research